Vascular Biogenics Ltd.
(NASDAQ : VBLT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -1.16%129.700.0%$1301.31m
OCGNOcugen, Inc. -15.79%8.810.0%$1056.19m
NVAXNovavax, Inc. -15.97%154.2992.9%$606.05m
AMGNAmgen, Inc. -0.62%222.551.3%$545.56m
VRTXVertex Pharmaceuticals, Inc. -0.30%207.821.9%$517.32m
REGNRegeneron Pharmaceuticals, Inc. 0.50%448.982.7%$505.72m
GILDGilead Sciences, Inc. 1.64%63.781.0%$487.94m
ILMNIllumina, Inc. -3.67%401.133.5%$458.99m
ALXNAlexion Pharmaceuticals, Inc. -0.05%148.112.0%$341.34m
BIIBBiogen, Inc. -0.36%265.641.7%$319.27m
CRSPCRISPR Therapeutics AG -4.49%113.730.6%$270.22m
BNGOBionano Genomics, Inc. -20.94%6.760.0%$239.07m
EXASEXACT Sciences Corp. -5.26%119.9118.4%$223.62m
SGENSeagen Inc. -1.37%145.915.8%$206.16m
PACBPacific Biosciences of California, Inc. -7.57%28.627.2%$151.42m

Company Profile

Vascular Biogenics Ltd. is in the clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of first-in-class treatments for cancer. Its programs include cancer, inflammation, and VB-600 which are focused on treating tumors, ovarian cancer, and chronic immune-related indications. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel.